These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 28697344)

  • 21. Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma.
    Zhao T; Jiang T; Li X; Chang S; Sun Q; Kong F; Kong X; Wei F; He J; Hao J; Xie K
    Clin Cancer Res; 2023 Dec; 29(24):5183-5195. PubMed ID: 37819952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy.
    Raykov Z; Grekova SP; Bour G; Lehn JM; Giese NA; Nicolau C; Aprahamian M
    Int J Cancer; 2014 Jun; 134(11):2572-82. PubMed ID: 24214898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer.
    Fu X; Tang N; Xie WQ; Mao L; Qiu YD
    Chin J Nat Med; 2020 Mar; 18(3):178-185. PubMed ID: 32245587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model.
    Brandes F; Schmidt K; Wagner C; Redekopf J; Schlitt HJ; Geissler EK; Lang SA
    BMC Cancer; 2015 Feb; 15():71. PubMed ID: 25884642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling.
    Cui J; Guo Y; Wu H; Xiong J; Peng T
    Mol Med; 2021 Apr; 27(1):38. PubMed ID: 33849427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
    Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
    Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Tadros S; Shukla SK; King RJ; Gunda V; Vernucci E; Abrego J; Chaika NV; Yu F; Lazenby AJ; Berim L; Grem J; Sasson AR; Singh PK
    Cancer Res; 2017 Oct; 77(20):5503-5517. PubMed ID: 28811332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer.
    Xi Y; Yuan P; Li T; Zhang M; Liu MF; Li B
    Cancer Lett; 2020 Jun; 479():112-122. PubMed ID: 32200037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.
    Liu Z; Jia X; Duan Y; Xiao H; Sundqvist KG; Permert J; Wang F
    Cancer Biol Ther; 2013 May; 14(5):428-35. PubMed ID: 23377827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H; Xie J; Peng J; Han Y; Jiang Q; Han M; Wang C
    Exp Cell Res; 2015 Mar; 332(2):236-46. PubMed ID: 25499970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
    Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G
    Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local Delivery of Gemcitabine Inhibits Pancreatic and Cholangiocarcinoma Tumor Growth by Promoting Epidermal Growth Factor Receptor Degradation.
    Jang SI; Fang S; Baek YY; Lee DH; Na K; Lee SY; Lee DK
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.
    Samulitis BK; Landowski TH; Dorr RT
    Invest New Drugs; 2009 Feb; 27(1):89-98. PubMed ID: 18607542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
    Ni J; Zhou S; Yuan W; Cen F; Yan Q
    J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
    [No Abstract]   [Full Text] [Related]  

  • 36. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3.
    Ahmmed B; Kampo S; Khan M; Faqeer A; Kumar SP; Yulin L; Liu JW; Yan Q
    J Cell Physiol; 2019 Jul; 234(7):10680-10697. PubMed ID: 30628067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer.
    Dang CV
    Cancer Cell; 2017 Jul; 32(1):3-5. PubMed ID: 28697341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells.
    Kato H; Seto K; Kobayashi N; Yoshinaga K; Meyer T; Takei M
    Life Sci; 2011 Oct; 89(17-18):603-8. PubMed ID: 21839751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.
    Gunda V; Souchek J; Abrego J; Shukla SK; Goode GD; Vernucci E; Dasgupta A; Chaika NV; King RJ; Li S; Wang S; Yu F; Bessho T; Lin C; Singh PK
    Clin Cancer Res; 2017 Oct; 23(19):5881-5891. PubMed ID: 28720669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.